{
    "nctId": "NCT03776721",
    "briefTitle": "Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting",
    "officialTitle": "Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Change in arm volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Unilateral arm lymphedema secondary to breast cancer treatment including lymph node dissection.\n* Cancer free for at least 1 year\n* The patient understands the nature and purpose of this study and the study procedures and has signed informed consent.\n* The opposite upper extremity is healthy (no lymphedema).\n* ASA score of 1 or 2.\n* The patient is able to read, understand, and complete Danish questionnaires.\n* Pitting lymphedema ISL grade 1 or 2.\n* A minimum circumference difference of 2cm or a minimum volume difference of 200mL.\n\nExclusion Criteria:\n\n* Pregnant or lactating.\n* Bilateral lymphedema\n* Current or previous malignancies other than breast cancer.\n* Insulin-dependent diabetes.\n* Diagnosed with any form of psychotic disorder, which may impact study participation.\n* Not ceased smoking during treatment.\n* Active implantables (e.g. pacemaker or neurostimulator)\n* Unrealistic treatment expectations.\n* Known hepatitis, HIV or syphilis infection.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}